Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onabotulinumtoxin A and hyaluronic acid fillers for facial paralysis
2018-004696-12Phase 2Completed
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- May 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of botulinum toxin type A and hyaluronic acid in facial palsy (2 arms), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: House-Brackmann scale improvement. Started May 2021; status: completed.
02
Drugs
botulinum toxin type Ahyaluronic acid
03
Conditions
facial palsy
Beyond the preview
Go deeper on 2018-004696-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004696-12.